Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Miyoshi

Showing results (51-60 of 178) with videos related to

Pageof 18
Sort By:
Molecular and Clinical Oncology|January 26, 2019
Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytesYukie Fujimoto, Hiromi Ozawa, Tomoko Higuchi, et al.
Cancer Science|July 12, 2016
HP1 regulates the localization of FANCJ at sites of DNA double-strand breaksWenwen Wu, Yukiko Togashi, Yoshikazu Johmura, et al.
Cancer Letters|October 11, 2003
Mutational analysis of BARD1 in familial breast cancer patients in JapanMakoto Ishitobi, Yasuo Miyoshi, Seiichi Hasegawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancerYasuo Miyoshi, Akiko Ando, Seiichi Hasegawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Association of serum adiponectin levels with breast cancer riskYasuo Miyoshi, Tohru Funahashi, Shinji Kihara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancersYuri Takahashi, Yasuo Miyoshi, Chie Takahata, et al.
Breast Cancer Research and Treatment|January 5, 2007
Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancerYasuto Naoi, Yasuo Miyoshi, Tetsuya Taguchi, et al.
Breast Cancer (Tokyo, Japan)|February 20, 2025
Development and internal validation of a predictive model of overall and progression-free survival in eribulin-treated patients with breast cancer based on baseline peripheral blood parametersKeiko Natori, Masataka Igeta, Takashi Morimoto, et al.
Breast Cancer (Tokyo, Japan)|April 28, 2023
An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancersReiko Fukui, Takahiro Watanabe, Koji Morimoto, et al.
Hepato-Gastroenterology|July 9, 2004
Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinomaTsutomu Fujito, Yo Sasaki, Kyoko Iwao, et al.
Pageof 18

Showing results (51-60 of 178) with videos related to

Sort By:
Pageof 18
Molecular and Clinical Oncology|January 26, 2019
Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytesYukie Fujimoto, Hiromi Ozawa, Tomoko Higuchi, et al.
Cancer Science|July 12, 2016
HP1 regulates the localization of FANCJ at sites of DNA double-strand breaksWenwen Wu, Yukiko Togashi, Yoshikazu Johmura, et al.
Cancer Letters|October 11, 2003
Mutational analysis of BARD1 in familial breast cancer patients in JapanMakoto Ishitobi, Yasuo Miyoshi, Seiichi Hasegawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancerYasuo Miyoshi, Akiko Ando, Seiichi Hasegawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Association of serum adiponectin levels with breast cancer riskYasuo Miyoshi, Tohru Funahashi, Shinji Kihara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancersYuri Takahashi, Yasuo Miyoshi, Chie Takahata, et al.
Breast Cancer Research and Treatment|January 5, 2007
Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancerYasuto Naoi, Yasuo Miyoshi, Tetsuya Taguchi, et al.
Breast Cancer (Tokyo, Japan)|February 20, 2025
Development and internal validation of a predictive model of overall and progression-free survival in eribulin-treated patients with breast cancer based on baseline peripheral blood parametersKeiko Natori, Masataka Igeta, Takashi Morimoto, et al.
Breast Cancer (Tokyo, Japan)|April 28, 2023
An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancersReiko Fukui, Takahiro Watanabe, Koji Morimoto, et al.
Hepato-Gastroenterology|July 9, 2004
Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinomaTsutomu Fujito, Yo Sasaki, Kyoko Iwao, et al.
Pageof 18